Perform Another (Advanced) Search

1.  Newly Approved Drug Therapies (948) AzaSite (azithromycin), InSite Vision,
...Newly Approved Drug Therapies (948) AzaSite (azithromycin), InSite Vision, Drug Information The following information is obtained from various newswires, published medical journal articles, and medical conference presentations. Drug Name: AzaSite (azithromycin) Company: InSite Vision Approval Status: Approved April 2007 Treatment Area: bacterial conjunctivitis General Information AzaSite ...
View Page

2.  Newly Approved Drug Therapies (130) Zithromax (azithromycin), Pfizer,
...Newly Approved Drug Therapies (130) Zithromax (azithromycin), Pfizer, Drug Information The following information is obtained from various newswires, published medical journal articles, and medical conference presentations. Drug Name: Zithromax (azithromycin) Company: Pfizer Approval Status: Approved June 1996 Treatment Area: Mycobacterium avium complex (MAC) General Information ...
View Page

3.  Study Posting (3736) Trial #154993, Eye Disorders/Infections, Philadelphia, PA
...and swollen or heavy eyelids? This study is to evaluate the safety and efficacy of Azithromycin Ophthalmic Solution, 1% versus a placebo Inclusion Criteria • 18 years of age or older • Best ...
...within 90 days of visit 2 • History of herpatic keratitis • Have a known hypersensitivity to azithromycin, erythromycin, or any other macrolide antibiotic Lisa Flynn or Kelleanne Miles, CCRC Philadelphia Eye Associates ...
View Page

4.  Study Posting (820) Trial #87420, Ear Infections, Paramount, CA
...Between 6 months to less than 6 years of age • Not allergic to macrolides or azithromycin (ie, Zithromax) • Able to swallow liquid medication • Has not taken an antibiotic in the last ...
View Page

5.  CenterWatch: Ophthalmology Approved Drug Therapies
...inflammation and pain associated with ocular surgery, Approved June 2008 Drugs Approved in 2007 AzaSite (azithromycin) ; InSite Vision; For the treatment of bacterial conjunctivitis, Approved April 2007 Drugs Approved in 2006 ...
View Page

6.  CenterWatch: List of Newly Approved Drug Thearapies
...the treatment of impetigo due to Staphylococcus aureus or Streptococcus pyogenes, Approved April 2007 AzaSite (azithromycin) ; InSite Vision; For the treatment of bacterial conjunctivitis, Approved April 2007 Doribax (doripenem) ; Johnson & Johnson ...
...2007 Tykerb (lapatinib) ; GlaxoSmithKline; For the treatment of breast cancer, Approved March 2007 Ophthalmology AzaSite (azithromycin) ; InSite Vision; For the treatment of bacterial conjunctivitis, Approved April 2007 Otolaryngology Veramyst (fluticasone furoate ...
View Page

7.  CenterWatch: Immunology/Infectious Diseases Approved Drug Therapies
...the treatment of impetigo due to Staphylococcus aureus or Streptococcus pyogenes, Approved April 2007 AzaSite (azithromycin) ; InSite Vision; For the treatment of bacterial conjunctivitis, Approved April 2007 Doribax (doripenem) ; Johnson & Johnson ...
...Vitrasert Implant ; Chiron; Drug delivery system for the treatment of cytomegalovirus, Approved March 1996 Zithromax (azithromycin) ; Pfizer; Treatment for Mycobacterium avium complex (MAC) in subjects with advanced HIV infection, Approved June ...
View Page

8.  CenterWatch: New Medical Therapies in Disease Category (227), Eye Disorders/Infections
...2005 InSite Vision has issued positive result of a phase III trial of AzaSite (DuraSite azithromycin) , their investigational anti- infective eye drops for the treatment of bacterial conjunctivitis. Trial data met ...
View Page

9.  CenterWatch: List of Newly Approved Drug Thearapies
...Vitrasert Implant ; Chiron; Drug delivery system for the treatment of cytomegalovirus, Approved March 1996 Zithromax (azithromycin) ; Pfizer; Treatment for Mycobacterium avium complex (MAC) in subjects with advanced HIV infection, Approved June ...
View Page